Could a tiny scrotal procedure ease prostate troubles without surgery?

NCT ID NCT07745621

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This trial tests a new device called Vivifi that aims to reduce symptoms of an enlarged prostate (BPH) by gently altering the blood supply to the prostate through a small scrotal procedure. The study involves 20 men aged 45–80 with moderate-to-severe urinary symptoms. Researchers will check how safe the procedure is and whether it improves urinary flow and symptoms over time, while also monitoring effects on ejaculatory function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Vivifi device – a minimally invasive percutaneous ablation device that modifies the prostate's blood supply via a scrotal approach
What this could lead to
If successful, this could offer a new, less invasive treatment option for men with enlarged prostate, potentially preserving sexual function while relieving urinary symptoms.
What could go wrong
This is a very early, small study (20 men) focused on safety and feasibility, so results may not hold up in larger trials. Risks include procedure-related side effects and the possibility that symptom relief is modest or temporary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN PROSTATIC HYPERPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Paitilla

    Panama City, Provincia de Panamá, Panama

More trials for these conditions

Other studies related to the condition(s) this trial covers.